Lincoln Pharmaceuticals (BOM:531633) ROCE % : 27.04% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Lincoln Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Lincoln Pharmaceuticals's annualized ROCE % for the quarter that ended in Dec. 2023 was 27.04%.

Lincoln Pharmaceuticals ROCE % Historical Data

The historical data trend for Lincoln Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lincoln Pharmaceuticals ROCE % Chart

Lincoln Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

23.07

21.23

24.25

23.74

21.38

Lincoln Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															25.72	14.07	20.08	26.61	27.04

Lincoln Pharmaceuticals ROCE % Calculation

Lincoln Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	1025.099	/	( ( (5343.572 - 904.862)	+	(5874.203 - 722.839) )	/ 2 )
	=	1025.099	/	( (4438.71	+	5151.364)	/ 2 )
	=	1025.099	/	4795.037
	=	21.38 %

Lincoln Pharmaceuticals's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	1514.604	/	( ( (6632.686 - 1031.815)	+	(0 - 0) )	/ 1 )
	=	1514.604	/	( ( 5600.871	+	0 )	/ 1 )
	=	1514.604	/	5600.871
	=	27.04 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Lincoln Pharmaceuticals (BOM:531633) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Lincoln Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Lincoln Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lincoln Pharmaceuticals (BOM:531633) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lincoln Pharmaceuticals Ltd (BOM:531633) » Definitions » ROCE %

Traded in Other Exchanges

LINCOLN:India

Address

Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060

Website

https://www.lincolnpharma.com

Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of Cardiac, Diabetic, Anti-malarial, Anti-biotic, Anti-fungal, Cephalosporin, Analgesic, Anaesthetics, Anti-pyretic, GIT products, Vitamin-Minerals, and Iron preparations. Geographically, the company carries out sales in India and outside India; generating key revenue from outside India.

Lincoln Pharmaceuticals (BOM:531633) Headlines

No Headlines